Evidence map›Paper›PMID 34144678›Full record

ArticleBMC infectious diseases2021

Hospital-based prospective study of pertussis in infants and close contacts in Tehran, Iran.

Gaelle Noel, Masoumeh Nakhost Lotfi, Sajedeh Mirshahvalad, Sedaghatpour Mahdi, David Tavel, Seyed M Zahraei, Roxana Mansour Ghanaie, Tahereh Heidary, Aliahmad Goudarzi, Azardokht Kazemi and 6 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02983487 (Pertussis Immunization Programs in Low Income Countries), which is not on this map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02983487 completednot on this map

Pertussis Immunization Programs in Low Income Countries

TypeobservationalSponsorInstitut PasteurRan2017 to 2019Enrolled3,587ConditionsBordetella Pertussis, Whooping CoughArmsNasopharyngeal sampling, Blood Sampling
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Observational
  6. Article
  7. [Pertussis worldwide. Vaccinating children and adults].Medecine tropicale et sante internationale · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Gaelle Noel *Center for Translational Science, Institut Pasteur, Paris, France. gaelle.noel@pasteur.fr.
Masoumeh Nakhost Lotfi *Department of Bacteriology, Pertussis Reference Laboratory, Pasteur Institute of Iran, Tehran, Islamic Republic of Iran.
Sajedeh MirshahvaladDepartment of Bacteriology, Pertussis Reference Laboratory, Pasteur Institute of Iran, Tehran, Islamic Republic of Iran.
Sedaghatpour MahdiDepartment of Bacteriology, Pertussis Reference Laboratory, Pasteur Institute of Iran, Tehran, Islamic Republic of Iran.
David TavelEmerging Diseases Epidemiology unit, Institut Pasteur, Paris, France.
Seyed M ZahraeiCenter for Communicable Diseases Control, Ministry of Health and Medical Education, Tehran, Islamic Republic of Iran.
Roxana Mansour GhanaiePediatric Infections Research Center, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Research Institute for Children's Health, Tehran, Islamic Republic of Iran.
Tahereh HeidaryDepartment of Pediatrics, Ali Asghar children hospital, Iran University of Medical Sciences, Tehran, Islamic Republic of Iran.
Aliahmad GoudarziPediatric cardiology department, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran.
Azardokht KazemiEmergency Department, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran.
Abdollah KarimiPediatric Infections Research Center, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Research Institute for Children's Health, Tehran, Islamic Republic of Iran.
Alireza NateghianDepartment of Pediatrics, Ali Asghar children hospital, Iran University of Medical Sciences, Tehran, Islamic Republic of Iran.
Mohand Ait-AhmedCentre for Translational Science, Clinical Coordination, Institut Pasteur, Paris, France.
Nicole Guiso *Center for Translational Science, Institut Pasteur, Paris, France.
Fereshteh Shahcheraghi *Department of Bacteriology, Pertussis Reference Laboratory, Pasteur Institute of Iran, Tehran, Islamic Republic of Iran.
Fabien Taieb *Center for Translational Science, Institut Pasteur, Paris, France.
Institut Pasteur · FRPasteur Institute of Iran · IRShahid Beheshti University of Medical Sciences · IRIran University of Medical Sciences · IRMinistry of Health and Medical Education · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPertussis remain a global health concern, especially in infants too young to initiate their vaccination. Effective vaccination and high coverage limit the circulation of the pathogen, yet duration of protection is limited and boosters are recommended during a lifetime. In Iran, boosters are given at 18 months and 6 years old using whole pertussis vaccines for which efficacy is not known, and pertussis surveillance is scant with only sporadic biological diagnosis. Burden of pertussis is not well understood and local data are needed.

methodsHospital-based prospective study implementing molecular laboratory testing in infants aged ≤6 months and presenting ≥5 days of cough associated to one pertussis-like symptom in Tehran. Household and non-household contact cases of positive infants were evaluated by comprehensive pertussis diagnosis (molecular testing and serology) regardless of clinical signs. Clinical evaluation and source of infection were described.

resultsA total of 247 infants and 130 contact cases were enrolled. Pertussis diagnosis result was obtained for 199 infants and 104 contact cases. Infant population was mostly < 3 months old (79.9%; 157/199) and unvaccinated (62.3%; 124/199), 20.1% (40/199) of them were confirmed having B. pertussis infection. Greater cough duration and lymphocyte counts were the only symptoms associated to positivity. Half of the contact cases (51.0%; 53/104) had a B. pertussis infection, median age was 31 years old. A proportion of 28.3% (15/53) positive contacts did not report any symptom. However, 67.9% (36/53) and 3.8% (2/53) of them reported cough at inclusion or during the study, including 20.8% (11/53) who started coughing ≥7 days before infant cough onset. Overall, only five samples were successfully cultured.

conclusionThese data evidenced the significant prevalence of pertussis infection among paucy or poorly symptomatic contacts of infants with pertussis infection. Widespread usage of molecular testing should be implemented to identify B. pertussis infections.

Indexed as

AdultChild, PreschoolFemaleHospitalsHumansInfantIranMaleMolecular Diagnostic TechniquesProspective StudiesWhooping CoughContactDiagnosisInfantInfectionPertussisVaccine complianceWhole-cell vaccine

Identifiers

PMID34144678
PMCPMC8212501
OpenAlexW3169533482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.